Verve Therapeutics
VERV
#6714
Rank
C$0.76 B
Marketcap
$8.58
Share price
-2.93%
Change (1 day)
-55.56%
Change (1 year)

Operating Margin for Verve Therapeutics (VERV)

Operating Margin as of March 2025 (TTM): -613.50%

According to Verve Therapeutics's latest financial reports and stock price the company's current Operating Margin is -613.50%. At the end of 2024 the company had an Operating Margin of -613.51%.

Operating Margin history for Verve Therapeutics from 2023 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-613.51%-63.89%
2023-1,699.21%-79.04%
2022-8,105.82%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.